Today's agenda In addition to results determined in accordance with accounting principles generally acospled in the United Statesof Americal (G40P), nanggement utilizes sertain nor-GAAP selling and nraketing expense, adjusted reseach and development expense, adjusted generaland administrative expense, and adjusted EBTDA for purposes of e-dauding grogong g purposes: Maraqqenent believes: that these non-GAP financial measures, when reviewed collectively with the Company is GAPP financial infromation provide u ...

◆ BEAUTYHEALTH® Q1 2023 Earnings Presentation May 10, 2023 Disclaime This Pesentation contains seriain fonard dobing statements. These statements may relate to, but re not limited to, expectations of fitnancial performance of The Beauty Wea expend flores, the htoduction of new products, expansion into new markets and the ability it execute certain strategul intistial ws. Some of the forward-booking schaments s "acped:" "suggeds," "dan: ""telieve," "fricend," "colinets," "thoreds," "broyads" "would" "would" ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________. Commission File Number: 001-39565 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 85-1908962 (State or o ...

Company Participants Conference Call Participants Korinne Wolfmeyer - Piper Sandler & Co. Margaret Kaczor - William Blair & Company Olivia Tong - Raymond James & Associates Jonathan Block - Stifel, Nicolaus & Company Oliver Chen - TD Cowen Allen Gong - JPMorgan Chase & Co. Bruce Jackson - The Benchmark Company Linda Bolton-Weiser - D.A. Davidson & Co. Navann Ty - BNP Paribas Exane Kyle Rose - Canaccord Genuity Operator Good day and welcome to The Beauty Health Company First Quarter 2023 Earnings Conference ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-39565 The Beauty Health Company (Exact name of registrant as specified in its charter) Delaware 85-1908962 (State or other jurisdiction of (I.R.S. Employer Identification No.) in ...

Conference Call Participants Good morning, and welcome to The Beauty Health Company's Fourth Quarter and Fiscal Year 2022 Earnings Conference Call. [Operator Instructions]. Beauty Health Co (NASDAQ:SKIN) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET Bruce Jackson - The Benchmark Company Jonathan Block - Stifel, Nicolaus & Company Olivia Tong - Raymond James & Associates Linda Bolton-Weiser - D.A. Davidson & Co. Korinne Wolfmeyer - Piper Sandler & Co. Allen Gong - JPMorgan Chase & Co. Kyle Ro ...

41% 72% 56% Net sales by segment ($mm) Q2 22 ■ Delivery Systems ■Consumables 2020 1. Trade-Up revenue only disaggregated in Q2 22. Q4 & FY 2022 financial highlights (cont'd) | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |--------------|----------------------|--------|---------------------|--------|-------|-----------------|--------------------|--------------|----------------------|--------------------------|---------|--------|--------| | | ■ Americas \n■ EMEA | | ■APA ...

The Beauty Health Company (NASDAQ:SKIN) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Eduardo Rodriguez - Senior Director of M&A and IR Andrew Stanleick - President and CEO Liyuan Woo - CFO Conference Call Participants Oliver Chen - Cowen Korinne Wolfmeyer - Piper Sandler Jon Block - Stifel Margaret Kaczor - William Blair Allen Gong - JPMorgan Ashley Helgans - Jefferies Kyle Rose - Canaccord Genuity Bruce Jackson - The Benchmark Company Devin Weinstein - Raymond James Lin ...

← BEAUTYHEALTH® Q3 2022 Earnings Presentation November 2022 2 This Presentation contains certain forward-looking statements. These statements may relate to, but are not limited to, expectations of future operating results or financial performance of The Beauty Health Company (the "Company"), the calculation of certain key financial and operating metrics, capital expenditures, the introduction of new products, expansion into new markets and the ability to execute certain strategic initiatives. Some of the fo ...

The Beauty Health Company (NASDAQ:SKIN) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Eduardo Rodriguez - Senior Director of M&A and Investor Relations Andrew Stanleick - President & Chief Executive Officer Liyuan Woo - Chief Financial Officer Conference Call Participants Maggie Boeye - William Blair Steph Wissink - Jefferies Oliver Chen - Cowen and Company Olivia Tong - Raymond James Korinne Wolfmeyer - Piper Sandler Jon Block - Stifel Allen Gong - JPMorgan Bruce Jackson - ...